细菌性赛提丁除氨酶作为胺核酸原药的多功能激活剂
Viktorija Preitakaitė1, Arūnas Kazlauskas2, Agota Aučynaitė1
1Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, 7 Saulėtekio Ave, LT-10257, Vilnius, Lithuania.
European journal of medicinal chemistry
|June 22, 2025
概括
研究人员开发了一个平台,使用细菌的cytidine deaminases (CDAs) 来激活5-fluoropyrimidine前药物. 这种方法对酶-原药癌症治疗具有前景,通过选择性向癌细胞.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在癌症化疗中,5-烯胺基核酸是至关重要的.
- 产药策略旨在提高药物的疗效,降低毒性.
- 酶原药疗法 (EPT) 使用特定的酶来激活目标部位的原药.
研究的目的:
- 开发一种用于修改和激活5- Pyrimidine 核酸原药的新平台.
- 为了利用细菌衍生型细胞氨酸脱氨酶 (CDAs) 进行向的前药激活.
- 评估CDA激活前药物在各种癌症细胞系中的疗效.
主要方法:
- 使用细菌CDAs (CDA_EH,CDA_F14,CDA_Lsp) 开发一个前药物激活平台.
- 合成和评估各种N4-acyl/alkyl-5-fluorocytidines和4-替代-5-fluoropyrimidine类似物.
- 在表达CDA的癌细胞系中评估前药激活和细胞毒性 (HCT116,MCF7,U87MG).
主要成果:
- 细菌CDAs有效地将5 - 烯胺类同类物转化为细胞毒性5 - - 2 - - - - - - - - - - - 脱氧) 氨酸.
- 产药激活导致表达CDAs的癌细胞系中的细胞活力降低.
- 该平台促进了对各种前药物化学结构的评估.
结论:
- 开发的平台可以为EPT选择最佳的酶和前药成分.
- 这一策略具有针对性癌症治疗的潜力,通过选择性地激活癌细胞中的前药物.
- 该平台的进一步开发可能会导致更有效,更少的毒性癌症治疗.
更多相关视频
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
2.7K
08:17A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD1
Published on: April 16, 2021
2.5K
相关概念视频
01:28Biosynthesis of Nucleic Acids
204
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
204
01:19Allosteric Proteins-ATCase
5.9K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.9K